Actividades asistenciales

VERTEBRAL BODY TREATMENT DEVICE WITH SIDE PORT
29/01/2026 - A medical device for treating a basivertebral nerve in a vertebral body of a patient includes an elongate shaft defining a central channel with a port proximate the distal end. The shaft further...
包含神经生长因子的药物制剂
30/01/2026 - 包含神经生长因子(NGF)和至少一种可药用赋形剂的适合于冻干的液体药物制剂。
MULTIFUNCTIONAL DNA NANOSPHERE, PREPARATION METHOD THEREFOR, AND USE THEREOF
29/01/2026 - A multifunctional DNA nanosphere, a preparation method therefor, and use thereof. An acid-responsive i-motif sequence, an EGFRvIII aptamer A32 sequence, and an MRI contrast agent Gd-DOTA-N3 are...
神经创伤治疗
30/01/2026 - ...
新型麦角林类和治疗心境障碍的方法
30/01/2026 - 本公开提供麦角林化合物及其在治疗心境障碍中的用途。提供了药物组合物和制备各种麦角林化合物的方法。
MTORC1调节剂及其用途
30/01/2026 - 本公开涉及MTORC1调节剂及其用途。具体地,本公开提供了对mTORC1显示高选择性和抑制活性的化合物和盐及其用于治疗疾病的用途。
ANTIBODY TARGETING ATRN PROTEIN OR ANTIGEN-BINDING FRAGMENT THEREOF, AND USE THEREOF
29/01/2026 - The present application relates to an antibody targeting an ATRN protein or an antigen-binding fragment thereof, and the use thereof, and belongs to the field of antibodies. The antibody or the...
METHODS FOR SELECTING MEDICATIONS FOR TREATING PATIENTS HAVING ATTENTION-DEFICIT HYPERACTIVITY DISORDER
29/01/2026 - Methods for selecting a medication for a patient are described that include determining the patient's genotype for a panel of genes, identifying a phenotype associated with the genotype for each...
PHARMACEUTICAL COMPOSITION FOR TREATING TDP-43 PROTEINOPATHY, AND PREPARATION METHOD THEREFOR AND USE THEREOF
29/01/2026 - The present invention belongs to the technical field of pharmaceuticals. Disclosed are a pharmaceutical composition for treating a TDP-43 proteinopathy, and a preparation method therefor and the...
植物薬組成物及びその使用方法
27/01/2026 - 本発明は、Alisma orientaleの根茎;Atractylodes macrocephalaの根;Citri reticulataeの果皮;Citri reticulatae virideの果皮;及びFolium...
HETEROARYL CARBOXAMIDE AND RELATED GPR84 ANTAGONISTS AND USES THEREOF
29/01/2026 - The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of GPR84, and the treatment of GPR84-mediated disorders.
NITRIC OXIDE RELEASING PRODRUGS OF MDA AND MDMA
29/01/2026 - Provided herein are compounds of Formula (I), Formula (II), and Formula (III) or pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, R7 and A are defined herein. Also...